Projects per year
Abstract
Daptomycin is a calcium-dependent cyclic lipodepsipeptide derived from the soil saprotroph Streptomyces roseosporus, and its antibiotic properties make it a key agent for treatment of drug-resistant Gram-positive infections. It is most commonly used clinically for the treatment of Gram-positive skin and skin structure infections (SSSI), Staphylococcus aureus bacteremia, and right-sided endocarditis infections associated with S. aureus, including methicillin resistant S. aureus (MRSA). It has also been used "off-label"for Enterococcal infections. There has been a tremendous amount of research investigating its mode of action, resistance mechanisms, and biosynthesis of this clinically important antimicrobial agent. Although we cover the latter aspects in detail, the primary focus of this review is to provide the most comprehensive and up-to-date reference for the medicinal chemist on the structure-activity-toxicity of this important class of lipopeptide antibiotics.
Original language | English |
---|---|
Pages (from-to) | 13266-13290 |
Number of pages | 25 |
Journal | Journal of Medicinal Chemistry |
Volume | 63 |
Issue number | 22 |
DOIs | |
Publication status | Published - 25 Nov 2020 |
-
Advancing innovative therapies against pandrug-resistant Gram-negative superbugs
Li, J. (Chief Investigator (CI)), Zhou, Q. (Primary Chief Investigator (PCI)), Rao, G. (Chief Investigator (CI)), Kaye, K. S. (Partner Investigator (PI)) & Velkov, T. (Partner Investigator (PI))
NIH - National Institutes of Health (United States of America)
1/07/19 → 30/06/25
Project: Other
-
A systems approach to combat the significant antibiotic resistance challenge: Novel therapeutic strategies, mechanistic discoveries, and drug development
Li, J. (Primary Chief Investigator (PCI))
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/23
Project: Research
-
Combating Deadly Gram-negative Lung Infections: An Inhalation and Systems Approach
Li, J. (Primary Chief Investigator (PCI)) & Velkov, T. (Chief Investigator (CI))
NIH - National Institutes of Health (United States of America)
1/08/17 → 31/07/22
Project: Research